MAIER PAUL V (CIK 1182615) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-15). Recent activity: Sell ISCO (32,802 shares), Buy ETON (50,000 shares), Sell ETON (36,387 shares), Sell ETON (13,485 shares), Sell ETON (128 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | International Stem Cell CORP (ISCO) | Director | Sell | 32,802 | $10,497 |
| 2026-08-31 | Eton Pharmaceuticals, Inc. (ETON) | Director | Buy | 50,000 | $189,000 |
| 2026-08-31 | Eton Pharmaceuticals, Inc. (ETON) | Director | Sell | 36,387 | $2.1M |
| 2026-08-31 | Eton Pharmaceuticals, Inc. (ETON) | Director | Sell | 13,485 | $811,932 |
| 2026-08-31 | Eton Pharmaceuticals, Inc. (ETON) | Director | Sell | 128 | $7,907 |
| 2026-08-31 | Eton Pharmaceuticals, Inc. (ETON) | Director | Buy | 12,500 | $91,375 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. (ETON) | Director | Buy | 50,000 | $189,000 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. (ETON) | Director | Sell | 36,387 | $2.1M |
| 2026-08-28 | Eton Pharmaceuticals, Inc. (ETON) | Director | Sell | 13,485 | $811,932 |
| 2026-08-28 | Eton Pharmaceuticals, Inc. (ETON) | Director | Sell | 128 | $7,907 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15